Fennec Pharmaceuticals (FENC) Short Interest Ratio & Short Volume $8.15 -0.17 (-1.98%) As of 01:28 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Short Interest Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Fennec Pharmaceuticals Short Interest DataFennec Pharmaceuticals (FENC) has a short interest of 1.42 million shares, representing 6.16% of the float (the number of shares available for trading by the public). This marks a -5.96% decrease in short interest from the previous month. The short interest ratio (days to cover) is 13.9, indicating that it would take 13.9 days of the average trading volume of 95,445 shares to cover all short positions.Current Short Interest1,420,000 sharesPrevious Short Interest1,510,000 sharesChange Vs. Previous Month-5.96%Dollar Volume Sold Short$11.40 millionShort Interest Ratio13.9 Days to CoverLast Record DateMay 31, 2025Outstanding Shares27,600,000 sharesFloat Size23,070,000 sharesShort Percent of Float6.16%Today's Trading Volume5,801 sharesAverage Trading Volume95,445 sharesToday's Volume Vs. Average6% Short Selling Fennec Pharmaceuticals? Sign up to receive the latest short interest report for Fennec Pharmaceuticals and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartFENC Short Interest Over TimeFENC Days to Cover Over TimeFENC Percentage of Float Shorted Over Time Fennec Pharmaceuticals Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 5/31/20251,420,000 shares $11.40 million -6.0%6.2%13.9 $8.03 5/15/20251,510,000 shares $9.89 million +4.1%6.5%15.9 $6.55 4/30/20251,450,000 shares $8.76 million +0.7%6.3%18 $6.04 4/15/20251,440,000 shares $7.56 million -4.0%6.2%17.6 $5.25 3/31/20251,500,000 shares $9.14 million +4.2%6.5%18.4 $6.09 3/15/20251,440,000 shares $9.37 million -25.4%6.3%17.8 $6.51 2/28/20251,930,000 shares $13.55 million -5.4%8.4%27.6 $7.02 2/15/20252,040,000 shares $13.63 million +4.6%8.9%21.3 $6.68 1/31/20251,950,000 shares $12.68 million -2.5%8.5%17.5 $6.50 1/15/20252,000,000 shares $11.44 million +1.0%8.7%16.9 $5.72 Get the Latest News and Ratings for FENC and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Fennec Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 12/31/20241,980,000 shares $12.51 million -6.2%8.7%16.7 $6.32 12/15/20242,110,000 shares $12.77 million +0.5%9.2%17.8 $6.05 11/30/20242,100,000 shares $12.73 million +12.3%9.2%17.3 $6.06 11/15/20241,870,000 shares $7.46 million +5.1%8.1%17.9 $3.99 10/31/20241,780,000 shares $7.76 million -3.3%7.8%19.5 $4.36 10/15/20241,840,000 shares $8.56 million -0.5%9.1%22.3 $4.65 9/30/20241,850,000 shares $9.25 million +0.5%8.1%21.6 $5.00 9/15/20241,840,000 shares $10.06 million No Change8.1%19 $5.47 8/31/20241,840,000 shares $10.25 million -3.7%8.0%19.2 $5.57 8/15/20241,910,000 shares $10.66 million -1.6%8.4%18.6 $5.58 7/31/20241,940,000 shares $12.55 million -0.5%8.5%14.3 $6.47 7/15/20241,950,000 shares $12.75 million +8.3%8.6%13.5 $6.54 6/30/20241,800,000 shares $11.00 million +1.7%8.0%11.9 $6.11 6/15/20241,770,000 shares $11.97 million No Change7.8%11.8 $6.76 5/31/20241,770,000 shares $12.00 million +1.7%7.9%10.6 $6.78 5/15/20241,740,000 shares $12.15 million -3.9%7.5%10.4 $6.98 4/30/20241,810,000 shares $16.62 million -3.2%7.8%13.7 $9.18 4/15/20241,870,000 shares $19.32 million +3.3%8.1%14.5 $10.33 3/31/20241,810,000 shares $20.13 million +7.1%9.1%16.4 $11.12 3/15/20241,690,000 shares $16.80 million -1.2%8.5%14.4 $9.94 2/29/20241,710,000 shares $16.19 million -2.3%8.6%13.9 $9.47 2/15/20241,750,000 shares $16.00 million -2.2%8.9%14.8 $9.14 1/31/20241,790,000 shares $17.88 million -3.8%9.1%15.3 $9.99 1/15/20241,860,000 shares $19.14 million -7.5%9.5%15.3 $10.29 12/31/20232,010,000 shares $22.55 million -1.5%9.2%15.6 $11.22 12/15/20232,040,000 shares $20.30 million +6.8%9.4%15 $9.95 11/30/20231,910,000 shares $16.43 million -2.6%8.8%19.1 $8.60 11/15/20231,960,000 shares $15.70 million +2.1%9.0%20.9 $8.01 10/31/20231,920,000 shares $13.21 million -0.5%8.7%23 $6.88 10/15/20231,930,000 shares $13.32 million +19.1%8.8%25.4 $6.90The Robotics Revolution has arrived … and one $7 stock could take off as a result. (Ad)Michael Robinson has been at the forefront of the technology market for over 40 years. Spotting some profitable trends in tech … well ahead of Wall Street. Like when he called Nvidia at a mere 80 cents a share. Or Bitcoin when it was trading for just $300. Throughout his illustrious career … Michael has given his followers almost 150 different chances to register triple-digit gains.Now he's identified his next potential winner. Click here to find out more. 9/30/20231,620,000 shares $12.17 million +1.3%7.4%22.7 $7.51 9/15/20231,600,000 shares $12.69 million -3.0%7.3%27.3 $7.93 8/31/20231,650,000 shares $13.46 million -0.6%7.5%15.2 $8.16 8/15/20231,660,000 shares $13.76 million +0.6%7.6%14.5 $8.29 7/31/20231,650,000 shares $14.70 million -2.9%7.5%13.3 $8.91 7/15/20231,700,000 shares $14.93 million -1.2%7.8%13.8 $8.78 6/30/20231,720,000 shares $15.19 million -1.2%7.9%13.6 $8.83 6/15/20231,740,000 shares $16.84 million +1.2%8.0%12.6 $9.68 5/31/20231,720,000 shares $13.04 million +17.0%7.9%19.1 $7.58 5/15/20231,470,000 shares $11.23 million No Change6.7%17 $7.64 10/31/2022547,400 shares $4.82 million +17.4%2.9%3.6 $8.80 10/15/2022466,300 shares $3.67 million -6.3%2.4%3.3 $7.87 9/30/2022497,800 shares $4.03 million +1.1%2.6%3.9 $8.10 9/15/2022492,200 shares $3.31 million +39.7%2.6%4.3 $6.72 8/31/2022352,300 shares $2.47 million +16.2%1.6%7.1 $7.00 8/15/2022303,100 shares $2.06 million +64.7%1.4%8 $6.79 7/31/2022184,000 shares $1.23 million +18.3%0.9%6.3 $6.68 7/15/2022155,500 shares $1.04 million -1.3%0.7%5.3 $6.72 6/30/2022157,600 shares $879.41 thousand -25.5%1.0%5.5 $5.58 6/15/2022211,400 shares $1.19 million -18.0%1.3%7.2 $5.61 5/31/2022257,900 shares $1.47 million -2.7%1.2%8 $5.71 5/15/2022265,100 shares $1.46 million -0.1%1.2%7.5 $5.52 4/30/2022265,300 shares $1.53 million -1.7%1.2%7.2 $5.78 4/15/2022269,800 shares $1.67 million -0.4%1.3%6.8 $6.20 3/31/2022270,800 shares $1.52 million -3.3%N/A5.9 $5.60 3/15/2022279,900 shares $1.46 million -0.7%1.3%4.8 $5.20 2/28/2022281,800 shares $1.58 million -5.8%1.3%4.1 $5.59 2/15/2022299,200 shares $1.45 million +2.6%1.4%2.1 $4.86 1/31/2022291,500 shares $1.36 million -7.5%1.4%1.9 $4.65 1/15/2022315,100 shares $1.46 million +4.0%N/A0 $4.63 12/31/2021302,900 shares $1.33 million -15.8%1.4%2 $4.40 12/15/2021359,700 shares $1.54 million -13.8%1.7%2.5 $4.28 11/30/2021417,400 shares $1.83 million -7.0%1.9%3.2 $4.39 11/15/2021448,900 shares $4.33 million -5.8%2.1%8.2 $9.65 10/29/2021476,400 shares $4.41 million +8.0%2.2%10.3 $9.26 10/15/2021441,000 shares $4.05 million -4.2%2.0%10.7 $9.19 9/30/2021460,400 shares $4.34 million -16.0%2.1%10 $9.42 9/15/2021547,800 shares $4.73 million -9.4%2.5%5.3 $8.64 8/31/2021604,900 shares $4.79 million -8.0%2.8%5 $7.92 8/13/2021657,800 shares $4.69 million -8.6%3.0%4.8 $7.13 7/30/2021719,300 shares $4.68 million -1.6%3.3%4.9 $6.51 7/15/2021731,300 shares $4.83 million +3.9%3.4%4.5 $6.61 6/30/2021703,700 shares $5.13 million -50.4%3.3%4.2 $7.29 6/15/20211,420,000 shares $9.40 million +3.7%6.6%9.9 $6.62 5/28/20211,370,000 shares $10.10 million -6.2%6.3%10.8 $7.37 5/14/20211,460,000 shares $9.05 million +2.8%6.7%12.5 $6.20 4/30/20211,420,000 shares $9.23 million +14.5%6.6%12.5 $6.50 4/15/20211,240,000 shares $8.00 million +14.8%N/A0 $6.45 3/31/20211,080,000 shares $6.97 million +8.0%5.6%10.4 $6.45 3/15/20211,000,000 shares $7.70 million +3.3%5.2%12.5 $7.70The Robotics Revolution has arrived … and one $7 stock could take off as a result. (Ad)Michael Robinson has been at the forefront of the technology market for over 40 years. Spotting some profitable trends in tech … well ahead of Wall Street. Like when he called Nvidia at a mere 80 cents a share. Or Bitcoin when it was trading for just $300. Throughout his illustrious career … Michael has given his followers almost 150 different chances to register triple-digit gains.Now he's identified his next potential winner. Click here to find out more. 2/26/2021967,900 shares $7.39 million +6.2%5.0%11.4 $7.64 2/12/2021911,300 shares $7.63 million +1.0%4.7%10.1 $8.37 1/29/2021902,600 shares $6.64 million -8.2%4.7%8.9 $7.36 1/15/2021983,200 shares $7.27 million -1.2%5.1%9.2 $7.39 12/31/2020994,700 shares $7.10 million -5.3%5.2%9.2 $7.14 12/15/20201,050,000 shares $7.95 million -13.2%5.4%7.9 $7.58 11/30/20201,210,000 shares $9.37 million -4.7%6.3%7.5 $7.74 11/15/20201,270,000 shares $10.86 million -5.9%6.6%6.7 $8.55 10/30/20201,350,000 shares $10.42 million +7.1%7.0%5.2 $7.72 10/15/20201,260,000 shares $9.25 million -10.0%6.7%3.2 $7.34 9/30/20201,400,000 shares $8.48 million +1.5%7.4%3.4 $6.06 9/15/20201,380,000 shares $8.42 million +17.0%7.3%2.9 $6.10 8/31/20201,180,000 shares $6.47 million +11.3%6.3%2.5 $5.48 8/14/20201,060,000 shares $6.01 million -4.5%5.6%2.4 $5.67 7/31/20201,110,000 shares $9.37 million -9.0%5.2%3 $8.44 7/15/20201,220,000 shares $10.35 million -10.3%5.7%4.8 $8.48 6/30/20201,360,000 shares $11.12 million +164.4%6.4%6 $8.18 6/15/2020514,400 shares $4.32 million -6.2%2.4%3.4 $8.39 FENC Short Interest - Frequently Asked Questions What is Fennec Pharmaceuticals' current short interest? Short interest is the volume of Fennec Pharmaceuticals shares that have been sold short but have not yet been closed out or covered. As of May 31st, traders have sold 1,420,000 shares of FENC short. 6.16% of Fennec Pharmaceuticals' shares are currently sold short. Learn More on Fennec Pharmaceuticals' current short interest. What is a good short interest ratio for Fennec Pharmaceuticals? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. FENC shares currently have a short interest ratio of 14.0. Learn More on Fennec Pharmaceuticals's short interest ratio. Which institutional investors are shorting Fennec Pharmaceuticals? As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Fennec Pharmaceuticals: Simplex Trading LLC. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission. What is a good short interest percentage for Fennec Pharmaceuticals? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 6.16% of Fennec Pharmaceuticals' floating shares are currently sold short. Is Fennec Pharmaceuticals' short interest increasing or decreasing? Fennec Pharmaceuticals saw a drop in short interest in May. As of May 31st, there was short interest totaling 1,420,000 shares, a drop of 6.0% from the previous total of 1,510,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Fennec Pharmaceuticals' float size? Fennec Pharmaceuticals currently has issued a total of 27,600,000 shares. Some of Fennec Pharmaceuticals' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Fennec Pharmaceuticals currently has a public float of 23,070,000 shares. How does Fennec Pharmaceuticals' short interest compare to its competitors? 6.16% of Fennec Pharmaceuticals' shares are currently sold short. Here is how the short interest of companies in the industry of "biological products, except diagnostic" compare to Fennec Pharmaceuticals: LENZ Therapeutics, Inc. (14.12%), Replimune Group, Inc. (12.12%), Immatics (4.32%), Vir Biotechnology, Inc. (12.93%), Anavex Life Sciences Corp. (33.06%), Taysha Gene Therapies, Inc. (16.04%), Iovance Biotherapeutics, Inc. (31.81%), Relay Therapeutics, Inc. (14.14%), Valneva SE (0.00%), Opthea Limited (0.36%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: SPDR S&P 500 ETF Trust ($64.96 billion), Invesco QQQ ($27.88 billion), iShares Russell 2000 ETF ($19.94 billion), iShares 20+ Year Treasury Bond ETF ($9.69 billion), Strategy Incorporated ($8.58 billion), SPDR S&P Biotech ETF ($5.72 billion), Invesco S&P 500 Equal Weight ETF ($5.45 billion), iShares iBoxx $ Investment Grade Corporate Bond ETF ($4.70 billion), Charter Communications, Inc. ($4.54 billion), and Industrial Select Sector SPDR Fund ($4.49 billion). View all of the most shorted stocks. What does it mean to sell short Fennec Pharmaceuticals stock? Short selling FENC is an investing strategy that aims to generate trading profit from Fennec Pharmaceuticals as its price is falling. FENC shares are trading up $0.12 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Fennec Pharmaceuticals? A short squeeze for Fennec Pharmaceuticals occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of FENC, which in turn drives the price of the stock up even further. How often is Fennec Pharmaceuticals' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including FENC, twice per month. The most recent reporting period available is May, 31 2025. More Short Interest Resources from MarketBeat Related Companies LENZ Therapeutics Short Interest Replimune Group Short Interest Immatics Short Interest Vir Biotechnology Short Interest Anavex Life Sciences Short Interest Taysha Gene Therapies Short Interest Iovance Biotherapeutics Short Interest Relay Therapeutics Short Interest Valneva Short Interest Opthea Short Interest Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:FENC) was last updated on 6/13/2025 by MarketBeat.com Staff From Our PartnersYour Bank Account Is No Longer SafeWhat If Washington Declared That: YOUR Money ISN'T Actually Yours? Sounds insane, but that's exactly what ...Priority Gold | SponsoredUtah’s New Oil FindThe Real Reason 218,000 Acres Just Vanished The government just quietly leased 218,000 acres in the middle ...Stansberry Research | SponsoredThe End of Elon Musk…?The End of Elon Musk? Don't make him laugh. Jeff Brown has been hearing this same tired story for years, an...Brownstone Research | SponsoredWhy July 22nd Could Mean Big Changes for Social SecurityIn a stunning move, President Trump has authorized an AI-led transformation of federal agencies, including Soc...Altimetry | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredJuly 2025 Rule Change to Impact Retirement InvestorsThere's a massive change from a new rule going into effect this July. And it's one the Big Banks are alread...Premier Gold Co | SponsoredBanks aren’t ready for this altcoin—are you?Donald Trump just fast-tracked TWO major crypto bills with an August deadline! Your window of opportunity i...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Fennec Pharmaceuticals Inc Please log in to your account or sign up in order to add this asset to your watchlist. Share Fennec Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
